You are here

  • Home
  • Archive
  • Volume 71, Issue 8
  • Residual homing of α4β7-expressing β1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab

Article metrics

Article menu
Inflammatory bowel disease
Original research
Residual homing of α4β7-expressing β1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab

 

Online download statistics by month:

Online download statistics by month: August 2021 to March 2024

AbstractFullPdf
Aug 2021363118
Sep 2021290234145
Oct 202110858865
Nov 20217566445
Dec 20216244437
Jan 20225454631
Feb 20227598542
Mar 2022120012665
Apr 202212587268
May 20225665926
Jun 20225945532
Jul 2022160116296
Aug 2022160110450
Sep 202236015662
Oct 202219419274
Nov 202216216053
Dec 202215415136
Jan 202312312036
Feb 202316516543
Mar 202315515464
Apr 2023949335
May 202313913369
Jun 202311311642
Jul 202311611448
Aug 2023888427
Sep 2023838137
Oct 202311310738
Nov 202315813532
Dec 202317216250
Jan 2024777473
Feb 20241019345
Mar 2024867761
Total1356835371645